» Authors » Jeffrey J Leow

Jeffrey J Leow

Explore the profile of Jeffrey J Leow including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 110
Citations 1606
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Haider M, Leow J, Green J, Dhillon C, Wong A, Zhou Y, et al.
BJUI Compass . 2025 Feb; 6(2):e495. PMID: 39917583
Objectives: The objective of this study is to identify healthcare inequities in referrals and diagnoses of suspected prostate cancer (PCa) in an ethnically diverse and socially deprived large urban region....
2.
Leow J, Lim E, Chen K
BJU Int . 2023 Oct; 133 Suppl 3:76. PMID: 37804137
No abstract available.
3.
Leow J, Yong D, Chong Y
Eur J Surg Oncol . 2023 Aug; 49(8):1329-1330. PMID: 37550011
No abstract available.
4.
Mossanen M, Ingham M, Leow J, Tinay I, Wang Y, Krasnow R, et al.
Urol Pract . 2023 Jun; 5(1):7-14. PMID: 37300180
Introduction: Although evidence supports the use of mitomycin C after transurethral bladder tumor resection in reducing recurrent disease, its adoption has been limited. Examinations of claims data may help in...
5.
6.
7.
Chiu P, Leow J, Chiang C, Mok A, Zhang K, Hsieh P, et al.
J Urol . 2023 May; 210(1):98. PMID: 37139611
No abstract available.
8.
Chong R, Leow J, Choo Z, Salada R, Yong D, Chong Y
World J Urol . 2023 Apr; 41(4):941-951. PMID: 37036497
Testicular cancer (TCa) commonly presents as a painless scrotal mass. It has been suggested that testicular self-examination (TSE) can help in early detection and thus potentially improve treatment outcomes and...
9.
Chiu P, Leow J, Chiang C, Mok A, Zhang K, Hsieh P, et al.
J Urol . 2023 Apr; 210(1):88-98. PMID: 37036248
Purpose: We compare Prostate Health Index, Prostate Health Index density, and PSA density in predicting clinically significant prostate cancer in MRI-guided prostate biopsy. Materials And Methods: This is a multicenter...
10.
Leow J, Ray S, Dason S, Singer E, Chang S
Urol Clin North Am . 2023 Mar; 50(2):285-303. PMID: 36948672
Because metachronous metastatic disease will develop in 20% to 40% of patients with presumed localized renal cell carcinoma (RCC) treated surgically, research is focused on neoadjuvant and adjuvant systemic therapy,...